Guangzhou Wondfo Biotech Co Ltd Working Capital to Net Assets Ratio
Guangzhou Wondfo Biotech Co Ltd working capital to net assets ratio. Guangzhou Wondfo Biotech Co Ltd (300482) has a Working Capital to Net Assets ratio of 42.7% as of March 2026. Working capital of CN¥2.38 Billion (current assets of CN¥3.46 Billion minus current liabilities of CN¥1.07 Billion) is measured against net assets of CN¥5.58 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. Check tangible equity quality of Guangzhou Wondfo Biotech Co Ltd to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Guangzhou Wondfo Biotech Co Ltd (2011–2025)
Working capital to net assets ratio of Guangzhou Wondfo Biotech Co Ltd from 2011 to 2025. This chart shows how Guangzhou Wondfo Biotech Co Ltd's Working Capital to Net Assets ratio has evolved across 15 annual periods from 2011 to 2025. As of March 2026, the ratio stands at 42.7%, reflecting working capital of CN¥2.38 Billion against net assets of CN¥5.58 Billion CNY. See Guangzhou Wondfo Biotech Co Ltd (300482) liquidity interval to measure how many days the company can operate on defensive assets alone.
Guangzhou Wondfo Biotech Co Ltd Working Capital to Net Assets Ratio by Year (2011–2025)
Guangzhou Wondfo Biotech Co Ltd working capital to net assets ratio by year from 2011 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Guangzhou Wondfo Biotech Co Ltd from 2011 to 2025, covering 15 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see how large is Guangzhou Wondfo Biotech Co Ltd's balance sheet.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 41.3% | CN¥2.26 Billion | CN¥5.47 Billion | CN¥3.30 Billion | CN¥1.04 Billion | ▼ -11.1 pp |
| 2024 | 52.5% | CN¥2.96 Billion | CN¥5.65 Billion | CN¥3.79 Billion | CN¥821.46 Million | ▼ -7.1 pp |
| 2023 | 59.6% | CN¥2.75 Billion | CN¥4.61 Billion | CN¥3.23 Billion | CN¥484.23 Million | ▲ +10.9 pp |
| 2022 | 48.7% | CN¥2.21 Billion | CN¥4.54 Billion | CN¥3.35 Billion | CN¥1.14 Billion | ▼ -2.5 pp |
| 2021 | 51.2% | CN¥1.79 Billion | CN¥3.50 Billion | CN¥2.59 Billion | CN¥791.54 Million | ▲ +1.9 pp |
| 2020 | 49.3% | CN¥1.48 Billion | CN¥2.99 Billion | CN¥2.27 Billion | CN¥793.45 Million | ▼ -3.4 pp |
| 2019 | 52.7% | CN¥1.30 Billion | CN¥2.46 Billion | CN¥1.74 Billion | CN¥443.40 Million | ▼ -5.4 pp |
| 2018 | 58.1% | CN¥1.25 Billion | CN¥2.15 Billion | CN¥1.77 Billion | CN¥523.62 Million | ▲ +9.6 pp |
| 2017 | 48.5% | CN¥576.70 Million | CN¥1.19 Billion | CN¥957.02 Million | CN¥380.32 Million | ▼ -20.1 pp |
| 2016 | 68.5% | CN¥585.93 Million | CN¥854.75 Million | CN¥726.20 Million | CN¥140.28 Million | ▼ -0.4 pp |
| 2015 | 69.0% | CN¥483.13 Million | CN¥700.64 Million | CN¥569.06 Million | CN¥85.93 Million | ▲ +21.1 pp |
| 2014 | 47.8% | CN¥149.86 Million | CN¥313.43 Million | CN¥233.50 Million | CN¥83.64 Million | ▲ +6.3 pp |
| 2013 | 41.5% | CN¥100.25 Million | CN¥241.47 Million | CN¥178.51 Million | CN¥78.26 Million | ▲ +11.6 pp |
| 2012 | 30.0% | CN¥54.66 Million | CN¥182.48 Million | CN¥155.68 Million | CN¥101.02 Million | ▲ +5.5 pp |
| 2011 | 24.5% | CN¥35.37 Million | CN¥144.61 Million | CN¥135.96 Million | CN¥100.59 Million | — |